Clinical Trial Update: Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Assessment of LIK066 in Healthy Subjects and in Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update assessing safety, tolerability, PK and PD of LIK066 in healthy subjects and patients with type 2 diabetes mellitus across Phase 1 and Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LIK066 (LIK066)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 1, Phase 2 | Status: COMPLETED